The inguinal skin: An important site of colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

Infection Control and Hospital Epidemiology

Volumn 31, Issue 4, 2010, Pages 427-428

  Buehlmann, Manuela ^a   Fankhauser, Hans ^a   Laffer, Reto ^a   Bregenzer, Thomas ^a   Widmer, Andreas F ^b  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INGUINAL REGION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; SKIN; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; ENTEROBACTERIACEAE; FEMALE; GROIN; HUMANS; MALE; MIDDLE AGED; SKIN; YOUNG ADULT;

EID: 77949554659     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/651309     Document Type: Article

References (8)

1. Cantón R, Novais A, Valverde A, et al. Prevalence and spread of extendedspectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(suppl 1):144-153.
2. Goossens H, Brabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the Mystic Program in Europe and the United States (1997- 2004). Diagn Microbiol Infect Dis 2005;53:257-264.
3. Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008;14(suppl 1):159-165.
4. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 2008;29:510-516.
5. Buehlmann M, Bruderer T, Frei R, Bucher, Widmer AF. Gram-negative bacteria producing extended-spectrum beta-lactamases-is eradication possible? In: Proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy., Washington, DC: American Society for Microbiology; 2008. Abstract K3455.
6. Harbarth S. Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL) decolonization study. No. NCT00826670. Clinical Trials Web site. http://www.clinicaltrials.gov/ct2/show/NCT00826670? termpNCT00826670&rankp1. Published January 20, 2009. Updated October 7, 2009. Accessed January 5, 2010.
7. Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR. Control of an outbreak of infection due to extended-spectrum β-lactamase-producing Escherichia coli in a liver transplantation unit. Clin Infect Dis 2001; 33:126-128.
8. Troche G, Joly LM, Guibert M, Zazzo JF. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6- year prospective survey. Infect Control Hosp Epidemiol 2005;26:161-165.